Localization of the ezrin binding epitope for advanced glycation endproducts

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 8, 2008, Pages 1570-1580

  McRobert, E Anne ^a   Tikoo, Anjali ^a   Cooper, Mark E ^b   Bach, Leon A ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Advanced glycation endproducts; Diabetes; Diabetic complications; Ezrin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BINDING PROTEIN; EPITOPE; EZRIN; GLUTATHIONE TRANSFERASE; GLYCOSYLATED ALBUMIN; HYBRID PROTEIN; LIGAND;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; DIABETES MELLITUS; DOSE RESPONSE; GLYCATION; IN VITRO STUDY; NONHUMAN; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; CYTOSKELETAL PROTEINS; EPITOPES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS;

EID: 43049170065     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.11.016     Document Type: Article

References (44)

1. Amieva M.R., Litman P., Huang L., Ichimaru E., and Furthmayr H. Disruption of dynamic cell surface architecture of NIH3T3 fibroblasts by the N-terminal domains of moesin and ezrin: In vivo imaging with GFP fusion proteins. J. Cell Sci. 112 (1999) 111-125
2. Araki N., Ueno N., Chakrabarti B., Morino Y., and Horiuchi S. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J. Biol. Chem. 267 15 (1992) 10211-10214
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
4. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54 (2005) 1615-1625
5. Crepaldi T., Gautreau A., Comoglio P.M., Louvard D., and Arpin M. Ezrin is an effector of HGF-mediated migration and morphogenesis in epithelial cells. J. Cell Biol. 138 (1997) 423-434
6. Du X.L., Edelstein D., Rossetti L., Fantus I.G., Goldberg H., Ziyadeh F., et al. Hyperglycaemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces PAI-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. USA 97 (2000) 12222-12226
7. Edwards S.D., and Keep N.H. The 2.7 Å crystal structure of the activated FERM domain of moesin: An analysis of structural changes on activation. Biochemistry 40 (2001) 7061-7068
8. Forbes J.M., Soulis T., Thallas V., Panagiotopoulos S., Long D.M., Vasan S., et al. Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia 44 (2001) 108-114
9. Gallicchio M.A., McRobert E.A., Tikoo A., Cooper M.E., and Bach L.A. Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner. J. Am. Soc. Nephrol. 17 (2006) 414-421
10. Gautreau A., Louvard D., and Arpin M. Morphogenic effects of ezrin require a phosphorylation-induced transition from oligomers to monomers at the plasma membrane. J. Cell Biol. 150 1 (2000) 193-203
11. Goel A., Colcher D., Koo J.-S., Booth B.J.M., Pavlinkova G., and Batra S.K. Relative position of the hexahistidine tag effects binding properties of a tumour-associated single-chain Fv construct. Biochim. Biophys. Acta 1523 (2000) 13-20
12. Hamada K., Shimizu T., Matsui T., Tsukita S., and Hakoshima T. Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J. 19 (2000) 4449-4462
13. Hammes H.P., Martin S., Federlin K., Geisen K., and Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc. Natl. Acad. Sci. USA 88 (1991) 11555-11558
14. Henry M.D., Agosti C.G., and Solomon F. Molecular dissection of radixin: Distinct and interdependent functions of the amino- and carboxyl-terminal domains. J. Cell Biol. 129 4 (1995) 1007-1022
15. Ishikawa H., Tamura A., Matsui T., Sasaki H., Hakoshima T., Tsukita S., et al. Structural conversion between open and closed forms of radixin: Low-angle shadowing electron microscopy. J. Mol. Biol. 310 (2001) 973-978
16. Kihara M., Schmelzer J.D., Poduslo J.F., Curran G.L., Nickander K.K., and Low P.A. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc. Natl. Acad. Sci. USA 88 (1991) 6107-6111
17. Kislinger T., Fu C., Huber B., Qu W., Taguchi A., Du Yan S., et al. N(epsilon)-(carboxymethyl) lysine adducts of proteins are ligands for the receptor for advanced glycation endproducts that activate cell signalling pathways and modulate gene expression. J. Biol. Chem. 274 (1999) 31740-31749
18. Koschinsky T., He C.J., Mitsuhashi T., Bucala R., Liu C., Buenting C., et al. Orally absorbed reactive glycation products (glycotoxins)-an environmental risk factor in diabetic nephropathy. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6474-6479
19. Krieg J., and Hunter T. Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin. J. Biol. Chem. 267 27 (1992) 19258-19265
20. Lott J.S., Coddington-Lawson S.J., Teesdale-Spittle P.H., and McDonald F.J. A single WW domain is the predominant mediator of the interaction between the human ubiquitin-protein ligase Nedd4 and the human epithelial sodium channel. Biochem. J. 2361 (2002) 481-488
21. McRobert E.A., Gallicchio M., Jerums G., Cooper M.E., and Bach L.A. The amino terminal domains of ERM proteins bind advanced glycation endproducts: An interaction that may play a role in the development of diabetic complications. J. Biol. Chem. 278 (2003) 25783-25789
22. Myint K.-M., Yamamoto Y., Doi T., Kato I., Harashima A., Yonekura H., et al. RAGE control of diabetic nephropathy in a mouse model. Effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes 55 (2006) 2510-2522
23. Nagaraj R.H., Sell D.R., Prabhakaram M., Ortwerth B.J., and Monnier V.M. High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10257-10261
24. Nice E.C., and Catimel B. Instrumental biosensors: New perspectives for the analysis of biomolecular interactions. Bioessays 21 (1999) 339-352
25. Oldfield M.D., Bach L.A., Forbes J.M., Nikolic-Paterson D., McRobert A., Thallas V., et al. Advanced glycation endproducts cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation endproducts (RAGE). J. Clin. Invest. 108 12 (2001) 1853-1863
26. Osawa M., Yamamoto Y., Munesue S., Murakami N., Sakurai S., Watanabe T., et al. De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts. Biochim. Biophys. Acta 1770 (2007) 1468-1474
27. Oshiro N., Fukata Y., and Kaibuchi K. Phosphorylation of moesin by Rho-associated kinase (Rho-kinase) plays a crucial role in the formation of microvilli-like structures. J. Biol. Chem. 273 52 (1998) 34663-34666
28. Ozdemir A.M., Hopfer U., Erhard P., Monnier V.M., and Weiss M.F. Processing advanced glycation end product-modified albumin by the renal proximal tubule and the early pathogenesis of diabetic nephropathy. Ann. N.Y. Acad. Sci. 1043 (2005) 625-636
29. Pearson M.A., Reczek D., Bretscher A., and Karplus P.A. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail. Cell 101 (2000) 259-270
30. Reiser K.M. Nonenzymatic glycation of collagen in aging and diabetes. Proc. Soc. Exp. Biol. Med. 218 (1998) 23-37
31. Schiekofer S., Andrassy M., Chen J., Rudofsky G., Schneider J., Wendt T., et al. Acute hyperglycaemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappa B in PBMCs. Diabetes 52 (2003) 621-633
32. Schleicher E., Weigert C., Rohrbach H., Nerlich A., Bachmeier B., and Freiss U. Role of glucoxidation and lipid oxidation in the development of atherosclerosis. Ann N. Y. Acad Sci 1043 (2005) 343-354
33. Schmidt A.-M., Vianna M., Gerlach M., Brett J., Ryan J., Kao C., et al. Isolation and characterisation of two binding proteins for advanced glycation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267 (1992) 14987-14997
34. Smith P.M., Cowan A., Milgram S.L., and White B.A. Tissue-specific regulation by estrogen of ezrin and ezrin/radixin/moesin-binding protein 50. Endocrine 22 2 (2003) 119-126
35. Smith W.J., Nassar N., Bretscher A., Cerione R.A., and Karplus P.A. Structure of the active FERM domain of ezrin: Conformational and mobility changes identify keystone interactions. J. Biol. Chem. 278 (2003) 4949-4956
36. Terawaki S.-I., Maesaki R., and Hakoshima T. Structural basis for NHERF recognition by ERM proteins. Structure 14 (2006) 777-789
37. Tikoo A., Vargo M., Ramesh V., Gusella J., and Maruta H. An anti-RAS function of neurofibromatosis type 2 gene product (NF2/Merlin). J. Biol. Chem. 269 (1994) 23387-23390
38. Tsukita S., and Yonemura S. Cortical actin organization: Lessons from ERM (Ezrin/Radixin/Moesin) proteins. J. Biol. Chem. 274 (1999) 34507-34510
39. Valencia J.V., Mone M., Koehne C., Rediske J., and Hughes T.E. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: Lack of activity of endotoxin-free albumin-derived advanced glycation end products. Diabetologia 47 (2004) 844-852
40. Valencia J.V., Weldon S.C., Quinn D., Kiers G.H., DeGroot J., TeKoppele J.M., et al. Advanced glycation end product ligands for the receptor for advanced glycation end products: Biochemical characterization and formation kinetics. Anal. Biochem. 324 1 (2004) 68-78
41. Vlassara H. Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues. Diabetes 41 Suppl. 2 (1992) 52-56
42. Wautier J.L., Zoukourian C., Chappey O., Wautier M.P., Guillausseau P.J., Cao R., et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 97 (1996) 238-243
43. Xiang G., Schinzel R., Simm A., Sebekova K., and Heidland A. Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsin. Kidney Int. 59 Suppl. 78 (2001) S-53-S-57
44. Yonemura S., Tsukita S., and Tsukita S. Direct involvement of ezrin/radixin/moesin (ERM)-binding membrane proteins in the organization of microvilli in collaboration with activated ERM proteins. J. Cell Biol. 145 (1999) 1497-1509